Yan Q. Fan

No. 154, Anshan Road
Xiaobailou, 300052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Chelator-Free 99mTc-Labeled Yttrium Oxide Nanoparticles for Dose-Dependent Early Biodistribution Tracking in Mice.

Chelator-Free 99mTc-Labeled Yttrium Oxide Nanoparticles for Dose-Dependent Early Biodistribution Tracking in Mice.

Journal: Molecular pharmaceutics

Published: November 27, 2025

Molecular hydrogen-mediated SIRT1 activation alleviates sepsis-associated encephalopathy by promoting mitophagy.

Molecular hydrogen-mediated SIRT1 activation alleviates sepsis-associated encephalopathy by promoting mitophagy.

Journal: European journal of medical research

Published: September 14, 2025

Predictive Value of NLRP3 Inflammasome Activation for Unstable Plaques and Major Adverse Cardiovascular Events in Coronary Heart Disease.

Predictive Value of NLRP3 Inflammasome Activation for Unstable Plaques and Major Adverse Cardiovascular Events in Coronary Heart Disease.

Journal: Journal of inflammation research

Published: July 10, 2025

Thromboxane receptor activation in dendritic cells mitigates sepsis by suppressing S100a8/a9-mediated neutrophil recruitment.

Thromboxane receptor activation in dendritic cells mitigates sepsis by suppressing S100a8/a9-mediated neutrophil recruitment.

Journal: Signal transduction and targeted therapy

Published: June 11, 2025

Correction: Promotion of NLRP3 autophagosome degradation by PV-K nanodevice for protection against macrophage pyroptosis-mediated lung injury.

Correction: Promotion of NLRP3 autophagosome degradation by PV-K nanodevice for protection against macrophage pyroptosis-mediated lung injury.

Journal: Journal of nanobiotechnology

Published: April 06, 2025

Reduced plasma levels of neuregulin-1 are associated with adverse outcomes in patients with atherosclerotic cardiovascular disease.

Reduced plasma levels of neuregulin-1 are associated with adverse outcomes in patients with atherosclerotic cardiovascular disease.

Journal: Frontiers in cardiovascular medicine

Published: March 26, 2025

Molecular hydrogen protects against sepsis-induced cardiomyopathy through improving Golgi stress-mediated autophagy, inflammation and apoptosis.

Molecular hydrogen protects against sepsis-induced cardiomyopathy through improving Golgi stress-mediated autophagy, inflammation and apoptosis.

Journal: British journal of pharmacology

Published: November 08, 2024

Promotion of NLRP3 autophagosome degradation by PV-K nanodevice for protection against macrophage pyroptosis-mediated lung injury.

Promotion of NLRP3 autophagosome degradation by PV-K nanodevice for protection against macrophage pyroptosis-mediated lung injury.

Journal: Journal of nanobiotechnology

Published: November 02, 2024

Interaction, diagnosis, and treatment of lung microbiota-NLRP3 inflammasome-target organ axis in sepsis.

Interaction, diagnosis, and treatment of lung microbiota-NLRP3 inflammasome-target organ axis in sepsis.

Journal: International immunopharmacology

Published: November 01, 2024

Long-term trends and comparison of the burden of lower respiratory tract infections in China and globally from 1990 to 2021: an analysis based on the Global Burden of Disease study 2021.

Long-term trends and comparison of the burden of lower respiratory tract infections in China and globally from 1990 to 2021: an analysis based on the Global Burden of Disease study 2021.

Journal: Frontiers in public health

Published: October 08, 2024

High concentration hydrogen attenuates sepsis-induced acute kidney injury by promoting mitochondrial biogenesis and fusion.

High concentration hydrogen attenuates sepsis-induced acute kidney injury by promoting mitochondrial biogenesis and fusion.

Journal: International immunopharmacology

Published: July 29, 2024

From bioinformatics to anti-inflammation and immune regulation: ACT001 in lipopolysaccharide-induced lung injury.

From bioinformatics to anti-inflammation and immune regulation: ACT001 in lipopolysaccharide-induced lung injury.

Journal: Allergologia et immunopathologia

Published: June 06, 2024

Showing 1-12 of 48

Last Updated: 09/26/2026